Sarepta Therapeutics (United States)

About

In recent decades, authors affiliated with Sarepta Therapeutics (United States) have published 407 papers, which have received a total of 15.1k indexed citations. Scholars at this organization have produced 239 papers in Molecular Biology, 82 papers in Genetics and 57 papers in Infectious Diseases on the topics of Muscle Physiology and Disorders (137 papers), Virus-based gene therapy research (64 papers) and RNA Interference and Gene Delivery (62 papers). Their work is cited by papers focused on Molecular Biology (9.5k citations), Genetics (2.7k citations) and Infectious Diseases (2.5k citations). Authors at Sarepta Therapeutics (United States) collaborate with scholars in United States, United Kingdom and Canada and have published in prestigious journals including Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences. Some of Sarepta Therapeutics (United States)'s most productive authors include Patrick L. Iversen, Ryszard Kole, Hong M. Moulton, Sidney Altman, Adrian R. Krainer, David A. Stein, Gayathri R. Devi, Adams Amantana, Steve D. Wilton and Jerry R. Mendell.

In The Last Decade

Sarepta Therapeutics (United States)

381 papers receiving 15.0k citations

Fields of papers published by authors at Sarepta Therapeutics (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Sarepta Therapeutics (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Sarepta Therapeutics (United States) at the time of their publication.

Countries citing scholars working at Sarepta Therapeutics (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Sarepta Therapeutics (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Sarepta Therapeutics (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarepta Therapeutics (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2026